e-learning
resources
Vienna 2012
Monday, 03.09.2012
Asthma: mechanisms of airway inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dose dependent effect of thrombomodulin in a murine model of allergen-induced asthma
T. Takagi, K. Fujiwara, M. Onishi, M. Naito, H. Fujimoto, T. Kobayashi, H. Kobayashi, C. D‘Alessandro-Gabazza, E. Gabazza, O. Taguchi (Tsu, Japan)
Source:
Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Session:
Asthma: mechanisms of airway inflammation
Session type:
Thematic Poster Session
Number:
2365
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Takagi, K. Fujiwara, M. Onishi, M. Naito, H. Fujimoto, T. Kobayashi, H. Kobayashi, C. D‘Alessandro-Gabazza, E. Gabazza, O. Taguchi (Tsu, Japan). Dose dependent effect of thrombomodulin in a murine model of allergen-induced asthma. Eur Respir J 2012; 40: Suppl. 56, 2365
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Protective effect of thrombomodulin in a murine model of allergen-induced asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Obesity enhances allergen-induced airway inflammation in a murine model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Effect of thrombin inhalation in a murine model of bronchial asthma
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008
Effect of neutrophil elastase inhibitor on airway inflammation and airway hyperresponsiveness in a murine model of asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Effect of oral procaterol on allergic inflammation examined by a murine asthmatic model
Source: Eur Respir J 2003; 22: Suppl. 45, 286s
Year: 2003
Cellular approach of salbutamol effects on chronic lung inflammation induced by OVA in murine model
Source: Eur Respir J 2004; 24: Suppl. 48, 127s
Year: 2004
Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Deficiency of MMP-19 promotes allergen-induced eosinophil burden and airway responsiveness in mice
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Influence of acid sphingomyelinase deficiency in a murine model of allergen-induced asthma
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 20s
Year: 2001
Effect of roflumilast on neutrophilic asthma model
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Influence of CpG-oligodeoxynucleotides and dexamethasone on remodeling and expression of MMP-9 in murine model of chronic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 224s
Year: 2006
Murine models of asthma
Source: Eur Respir J 2003; 22: 374-382
Year: 2003
Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Activated protein C inhibits bronchial inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 618s
Year: 2002
Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept